The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT01694953
- Status
- Recruiting
Conditions
- Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in future clinical trials. Additional clinical centers will be listed as they become available.
Key Dates
- Start date
- Feb 28, 2013
- Status verified
- Apr 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Patients with MNGIEPatients of all races of any gender who are at least 5 years of age with a defect in thymidine phosphorylase may participate in this natural history study.
Primary Outcome Measure
Timed Water Swallow [ Time Frame: 5 years ]
Central Contacts
- Kris Engelstad, MS212-305-6834
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University | New York | New York | 10032 | Michio Hirano, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By research site